Clinical benefits of adjuvant chemotherapy with carboplatin and gemcitabine in patients with non-small cell lung cancer: a single-center retrospective study.

Shinogu TakashimaKazuhiro ImaiMaiko AtariTsubasa MatsuoKatsutoshi NakayamaYusuke SatoSatoru MotoyamaHiroyuki ShibataKyoko NomuraYoshihiro Minamiya

Published in: World journal of surgical oncology (2020)

CBDCA + GEM was effective and well tolerated as adjuvant chemotherapy, with a manageable toxicity profile.

Keyphrases